OverviewPsoriasis causes patches of red, scaly skin. It happens because your body has an overactive immune system. What is psoriasis?
Psoriasis is an autoimmune condition that causes inflammation in your skin. Symptoms of psoriasis include thick areas of discolored skin covered with scales. These thick, scaly areas are called plaques.
Psoriasis is a chronic skin condition, which means it can flare up unexpectedly and theres no cure.
There are several types of psoriasis, including:
A psoriasis rash can show up anywhere on your skin. Psoriasis is common on your:
In most people, psoriasis covers a small area of their skin. In severe cases, the plaques connect and cover a large area of your body.
Psoriatic arthritis is a type of arthritis that causes joint pain and swelling. Similar to psoriasis, psoriatic arthritis is an autoimmune condition that causes your immune system to function abnormally and cause symptoms. About 1 in 3 people diagnosed with psoriasis will also develop arthritis due to inflammation. Early treatment of psoriatic arthritis can reduce damage to your joints.
People of any age, sex or race can get psoriasis. Psoriasis affects millions of people. More than 3% of the U.S. population has psoriasis.
Psoriasis and eczema are two different skin conditions. Both conditions cause similar symptoms like discolored skin, a rash and itching. Psoriasis plaques cause areas of thick skin covered in scales. Eczema causes a rash of dry and bumpy skin. Eczema also typically causes more intense itching than psoriasis.
Symptoms of psoriasis on your skin include plaques. Plaques look like:
An early sign of psoriasis is small bumps. The bumps grow, and scales form on top. The surface of the plaque might shed, but the scales beneath them will stick together. If you scratch your rash, the scales may tear away from your skin. This can cause bleeding. As the rash continues to grow, lesions (larger areas of skin damage) can form. Symptoms of psoriasis can range from mild to severe.
In addition to skin plaques or a rash, you might have symptoms that include:
If you scratch your plaque, you could break open your skin, which could lead to an infection. Infections are dangerous. If you experience severe pain, swelling and a fever, you have symptoms of an infection. Contact your healthcare provider if you have these symptoms.
An over-reactive immune system that creates inflammation in your skin causes psoriasis.
If you have psoriasis, your immune system is supposed to destroy foreign invaders, like bacteria, to keep you healthy and prevent you from getting sick. Instead, your immune system can mistake healthy cells for foreign invaders. As a result, your immune system creates inflammation or swelling, which you see on the surface of your skin as skin plaques.
It usually takes up to 30 days for new skin cells to grow and replace old skin cells. Your over-reactive immune system causes the timeline of new skin cell development to change to three to four days. The speed of new cells replacing old cells creates scales and frequent skin shedding on top of skin plaques.
Psoriasis runs in families. There may be a genetic component to psoriasis because biological parents may pass the condition down to their children.
An outbreak of psoriasis, or a flare up, causes symptoms of psoriasis as a result of contact with a trigger, which could be an irritant or an allergen. Psoriasis outbreaks differ from person to person. Common triggers for psoriasis flare ups include:
No, psoriasis isnt contagious. You cant get psoriasis by coming into contact with another persons psoriasis skin rash.
A healthcare provider or a dermatologist will diagnose psoriasis after a physical exam to look at your skin and review your symptoms. Theyll ask you questions that could include:
The appearance of a skin plaque leads to a psoriasis diagnosis, but symptoms can relate to other similar skin conditions, so your provider might offer a skin biopsy test to confirm your diagnosis. During this test, your provider will remove a small sample of skin tissue from your skin plaque and examine it under a microscope.
Several treatment options can relieve psoriasis symptoms. Common psoriasis treatments include:
Creams or ointments may be enough to improve the rash in small areas of your skin. If your rash affects larger areas, or if you also have joint pain, youll need other treatments. Joint pain may be a sign that you have arthritis.
Your provider will decide on a treatment plan based on:
If your symptoms of psoriasis dont improve after treatment, or if you have large areas of involvement (10% of your skin or more), your healthcare provider may recommend the following treatments:
Before starting treatment, talk to your healthcare provider about the side effects and mention any medications or supplements you currently take to avoid drug interaction.
For some people diagnosed with psoriasis, the skin condition causes more than itchiness, scaling skin and skin discoloration. It can lead to swollen joints and arthritis. If you have psoriasis, you may be at higher risk of:
If you have psoriasis, your provider will do regular blood pressure checks and monitor the progress of your treatment to avoid complications. You can take steps to prevent potential complications by:
A flare-up of psoriasis symptoms can last a couple of weeks to a few months. Your healthcare provider can speed up your skins recovery with certain medications. After your symptoms go away, your psoriasis is in remission. This means that you could have another outbreak of symptoms in the future. Your remission timeline could last a few months to a couple of years. If you notice your symptoms flare up when you contact certain triggers, avoiding those triggers leads to a long remission time.
There isnt a way to entirely prevent psoriasis. You can reduce your risk by following your healthcare providers treatment, living a healthy lifestyle, taking good care of your skin and avoiding triggers that can cause an outbreak of symptoms.
If you have psoriasis, its common to see symptoms show up during early adulthood, but the timeline of when symptoms begin is unique to every person. You may notice certain triggers in your environment that can cause a flare up of symptoms. Avoiding these triggers can lead to fewer outbreaks in the future.
Psoriasis can make you uncomfortable, itchy and self-conscious. If these symptoms are causing you physical or emotional distress, contact your healthcare provider for treatment.
There isnt a cure for psoriasis. Psoriasis is a chronic condition, which means that symptoms may come and go throughout your life. Treatment can relieve symptoms so you can look and feel your best.
To feel your best with psoriasis:
Other steps you should take to stay as healthy as possible:
Do regular skin self-exams to notice any changes in your skin. If you have skin changes, a rash thats not going away or a rash that gets worse, contact your healthcare provider.
A note from Cleveland Clinic
Psoriasis, an itchy skin condition, can come and go throughout your life. Its related to an overactive immune response and isnt contagious. If you have skin changes that arent going away, talk to your healthcare provider. There isnt a cure for psoriasis, but psoriasis treatments can improve symptoms. Your provider may prescribe a special cream or moisturizer or medications. Other therapies are available if creams or medicines dont work. Maintaining your overall health will also help improve symptoms.
Read the rest here:
Psoriasis: What It Is, Symptoms, Causes, Types & Treatment
- Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment ... - Dermatology Times - April 18th, 2024 [April 18th, 2024]
- Psoriasis Patients with Arthralgia At Increased Risk of Psoriatic Arthritis Development - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Diagnosing Psoriatic Arthritis for the Dermatologist: Guidance From the Experts - Medscape - April 18th, 2024 [April 18th, 2024]
- Secukinumab 300 mg May Improve PsA or Active Psoriasis More Than 150 mg - MD Magazine - April 18th, 2024 [April 18th, 2024]
- The Impact of Pediatric Plaque Psoriasis on Children and Caregivers - HMP Global Learning Network - April 18th, 2024 [April 18th, 2024]
- Guselkumab Led to Improvements Over Several Psoriatic Arthritis Disease Domains - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Dual Diagnosing and Managing Psoriasis and Psoriatic Arthritis - The Dermatologist - April 18th, 2024 [April 18th, 2024]
- Etanercept Effective for Psoriasis, Rheumatic Disease Among Patients Extending Treatment After 12-Weeks - MD Magazine - February 9th, 2024 [February 9th, 2024]
- High Response Rates in Psoriasis With Oral IL-23 Inhibitor - Medpage Today - February 9th, 2024 [February 9th, 2024]
- Psoriasis and eczema have complex causes and consequences that researchers are seeking to uncover - Medical Xpress - February 9th, 2024 [February 9th, 2024]
- New Hope in Treatment of Plaque Psoriasis: Study Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- No Difference in Psoriasis Immune Response Despite Switch Between AVT02, Adalimumab - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Oral IL-23 Receptor Antagonist Peptide Effective in PASI Reduction for Psoriasis - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Breakthrough in Psoriasis Treatment: JNJ-77242113 Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from Phase II Trial of Oral Interleukin Inhibitor for Psoriasis Treatment - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from the FRONTIER 1 Trial - An Exploration of JNJ-77242113 in the Treatment of Moderate-to ... - Medriva - February 9th, 2024 [February 9th, 2024]
- Personal Experience with Psoriatic Arthritis and Atopic Dermatitis - Medriva - February 9th, 2024 [February 9th, 2024]
- Rising Cost of Stelara: Impact on Patients and Johnson & Johnson's Market Performance - Medriva - February 9th, 2024 [February 9th, 2024]
- Global Psoriatic Arthritis (PsA) Treatment Market to achieve a remarkable US$ 15.6 Billion by 2028, - PharmiWeb.com - February 9th, 2024 [February 9th, 2024]
- Tremfya potential highlighted by industry analyst GlobalData - The Pharma Letter - May 31st, 2023 [May 31st, 2023]
- Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Janssen Announces Positive Results From Guselkumab Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Early Intervention with Secukinumab May Be Effective for Patients ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Scratching the itch, Lynk Pharmaceuticals trialling ointment for ... - OutSourcing-Pharma.com - May 31st, 2023 [May 31st, 2023]
- Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- For Patients With Birthmarks, Psychosocial Interventions Improved ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Robert Hariri, MD: Natural Killer Cell Therapy Shows Remarkable ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Nalbuphine ER Tablets Show Promise as Cough Therapy in ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Benefit of Empagliflozin in HFpEF Consistent Regardless of Diuretic ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- selectION reports results from SAD stage of si-544 Phase Ib trial - Clinical Trials Arena - May 31st, 2023 [May 31st, 2023]
- No Link Observed Between Gastrointestinal Tract Surgery and New ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Lynk doses first cohort in Phase Ib trial of psoriasis therapy - Clinical Trials Arena - May 30th, 2023 [May 30th, 2023]
- Metabolic Inflammation Contributes to Depression in Psoriatic Disease - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Encouraging Diversity and Inclusion for Patients With Psoriatic ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- The Weekly Roundup: May 22-26 - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Pediatric Psoriasis Market: A Study of the Industry's Key Applications ... - The Navajo Post - May 30th, 2023 [May 30th, 2023]
- Phototherapy Lamps Market are set to witness a CAGR of 5.8 ... - Digital Journal - May 30th, 2023 [May 30th, 2023]
- Celltrion seeks approval for Stelara biosimilar in EU - The Investor - May 30th, 2023 [May 30th, 2023]
- Peter Marinkovich, MD: FDA Approval of B-VEC Gene Therapy for ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Nick Stucky, MD, Phd: Implications for Media Influence on Minoxidil ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Tildrakizumab Linked With HRQOL Improvement in Psoriasis in a Real-World Setting - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Clinical Utility of Deucravacitinib for the Management of Moderate to ... - Dove Medical Press - May 18th, 2023 [May 18th, 2023]
- Covid-19 and Psoriasis: Is there a link? - Dunya News - May 18th, 2023 [May 18th, 2023]
- Improvement Needed in Study Interventions to Better Skin Self ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Reviva Pharmaceuticals Announces Intent to File an IND for Brilaroxazine in Psoriasis After Promising Preclinical Data - Marketscreener.com - May 18th, 2023 [May 18th, 2023]
- Adam Friedman, MD: Addressing Disparities in Care for Patients ... - MD Magazine - May 18th, 2023 [May 18th, 2023]
- Early-Infancy Meningitis Infection Linked With Increased Risk of ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- NOVN: Counting Down to PDUFA - Yahoo Finance - May 18th, 2023 [May 18th, 2023]
- Psoriatic Arthritis (PsA) Treatment Market is likely to register CAGR ... - Future Market Insights - May 18th, 2023 [May 18th, 2023]
- New campaign raises awareness of topical steroid withdrawal - Professional Beauty - May 18th, 2023 [May 18th, 2023]
- MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody sonelokimab in... - February 2nd, 2023 [February 2nd, 2023]
- EVELO BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events (form 8-K) -... - February 2nd, 2023 [February 2nd, 2023]
- 12 Ways to Treat Psoriasis at Home - Healthline - January 22nd, 2023 [January 22nd, 2023]
- DTC Advertising Of Prescription Drugs In The U.S. Often Promotes Products With Comparatively Low Therapeutic Value - Forbes - January 19th, 2023 [January 19th, 2023]
- Types of Psoriasis: Pictures, Symptoms and Treatments - Healthline - December 18th, 2022 [December 18th, 2022]
- Psoriasis Pathogenesis and Treatment - PMC - PubMed Central (PMC) - November 23rd, 2022 [November 23rd, 2022]
- Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? - November 23rd, 2022 [November 23rd, 2022]
- Im a Dermatologist and These 7 Things Could Be Making Your Psoriasis Worse - Well+Good - October 19th, 2022 [October 19th, 2022]
- 'Worst time of the year for me to be covered in scabs': Amber Heard's Alleged Ex Cara Delevingne Revealed Her Psoriasis Struggle Made Kate Moss Scream... - October 19th, 2022 [October 19th, 2022]
- What is psoriasis and which foods ease symptoms? - Evening Standard - October 17th, 2022 [October 17th, 2022]
- Chronic inflammatory diseases: what they are - Emergency Live International - October 17th, 2022 [October 17th, 2022]
- How remote care can deliver a step change in treatment for inflammatory skin conditions - PoliticsHome - October 17th, 2022 [October 17th, 2022]
- Probiotics Supplementation may Improve Symptoms of Hyperuricemia and Gout - Rheumatology Network - October 15th, 2022 [October 15th, 2022]
- Psoriasis Pathogenesis and Treatment - PubMed - October 2nd, 2022 [October 2nd, 2022]
- Best and Worst Drinks for Psoriasis - Everyday Health - October 2nd, 2022 [October 2nd, 2022]
- These Are the 10 Most Common Chronic Skin Conditionsand the Most Important Facts to Know About Them - Parade Magazine - October 2nd, 2022 [October 2nd, 2022]
- Survey Addresses Concerns Regarding Reproductive Healthcare Communication in Women with RA, PsA - Rheumatology Network - October 2nd, 2022 [October 2nd, 2022]
- Psoriasis Types, Symptoms & Causes | NIAMS - September 29th, 2022 [September 29th, 2022]
- What Is Psoriasis And Can It Be Treated? - Forbes - September 29th, 2022 [September 29th, 2022]
- Plaque Psoriasis Treated With Tildrakizumab Shown to be Effective in Real-World Settings - MD Magazine - September 29th, 2022 [September 29th, 2022]
- Alumis Announces Initiation of Patient Dosing in Phase 2 Clinical Trial of ESK-001 for the Treatment of Plaque Psoriasis - Business Wire - September 29th, 2022 [September 29th, 2022]
- 15 Items That Will Make Your Life With Psoriatic Arthritis Easier - BlackDoctor.Org - September 29th, 2022 [September 29th, 2022]
- Types of Psoriasis and Their Effects on the Immune System - Cureus - September 27th, 2022 [September 27th, 2022]
- MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody sonelokimab in patients with active psoriatic arthritis - BioSpace - September 27th, 2022 [September 27th, 2022]
- How diversity and inclusion continues to be incorporated in dermatology - PMLiVE - September 27th, 2022 [September 27th, 2022]
- Arcutis Announces Topline Results From ARRECTOR Pivotal Phase 3 Trial Of Roflumilast Foam 0.3% In Scalp A - Benzinga - September 27th, 2022 [September 27th, 2022]
- Psoriasis Treatment Market Size to Hit USD 51.24 Bn by 2030 - GlobeNewswire - August 15th, 2022 [August 15th, 2022]
- Ventyx Sees Initiation Of Mid-Stage Psoriasis Study In Q4 2022 Following Positive Data From Initial-Stage - Benzinga - August 15th, 2022 [August 15th, 2022]
- Woman, 29, Slams Bullies Who 'Giggle And Whisper' At Her Unsightly Psoriasis Sores And Scabs, Leaving Her Depressed And 'Struggling To Walk' -... - August 15th, 2022 [August 15th, 2022]